Skip to main content

Tweets

New GoutStop cards - print and give to your gout patients! https://t.co/Bh0IuM5tzu https://t.co/j5rQJStSnu
Dr. John Cush @RheumNow ( View Tweet )
10 minutes 41 seconds ago
Catch up with Dr. Christina Charles-Schoeman and Dr. Manish Jain ahead of their upcoming episode! šŸ” Relisten to their 2025 discussion on achieving disease control in RA after TNFi failure. Sponsored by AbbVie Medical Affairs + Health Impact. https://t.co/Vz5spUucyl https://t.co/4gRT5CAp4b
Dr. John Cush @RheumNow ( View Tweet )
1 hour 39 minutes ago
Gout: Diagnosis The diagnosis of gout - labs, imaging and polarized microscopy, created by @MithuRheum for RheumNow. https://t.co/dM0jg0PQwB https://t.co/XVNFdvl0TG
Dr. John Cush @RheumNow ( View Tweet )
3 hours 5 minutes ago
Uricase-Targeted Therapies in Gout https://t.co/RB6Yj4oY9a https://t.co/NrWq6Y93Hg
Dr. John Cush @RheumNow ( View Tweet )
15 hours 40 minutes ago
The Wider Implications of Dactylitis Dactylitis, AKA the "sausage digit", is a hallmark of psoriatic arthritis (PsA), but as Possemato and colleagues point out, it is fundamentally a clinical sign, and not a diagnosis. https://t.co/HRaIvMHMSV https://t.co/XOcHbFVMsS
Dr. John Cush @RheumNow ( View Tweet )
17 hours 10 minutes ago
When Gout Flares, So Does the Cardiovascular System We have spent decades teaching that a gout flare is a joint problem: a hot, swollen, painful joint that we treat with anti-inflammatory drugs and move on from (i.e., the treat to avoid symptoms strategy). The campaign title https://t.co/HCUQVaor4f
Dr. John Cush @RheumNow ( View Tweet )
20 hours 40 minutes ago
Yesterday the EMA approved upadacitinib (Rinvoq) for the Treatment of Adults and Adolescents with Non-Segmental Vitiligo - the 1st therapy approved for the most common form of vitiligo. Based on positive results from the Phase 3 Viti-Up trials https://t.co/MMv5LjZclQ https://t.co/zN41GC5T15
Dr. John Cush @RheumNow ( View Tweet )
22 hours 11 minutes ago
Upgrading & Maximizing the Classics Panelists: Dr. Angelo Gaffo Dr. Lisa Stamp Dr. Michael Pillinger Dr. Ted Mikuls Dr. Jack Cush (moderator) https://t.co/gO4CQD2f19 https://t.co/ESSLL0iK8F
Dr. John Cush @RheumNow ( View Tweet )
22 hours 39 minutes ago
2 T2T RCTs of 383 gout pts starting allopurinol - 31% had tophi. At 12 mos achieving target uric acid (<0.36mmol/L) was same in pts with and without tophi (70.3 vs 73.6), as was the %gout flares in month 11 (71.4% vs 79.7%; p=0.21). Allopurinol T2T success not influenced by https://t.co/zr7K8Y2Bqz
Dr. John Cush @RheumNow ( View Tweet )
1 day ago
Swimming Reduces Disability from Low Back Pain Swimming is commonly recommended for patients with chronic low back pain. Yet, there is little trial data investigating swimming. An Australian study has shown for the first time that a program of swimming can be clinically https://t.co/OfxsvRjyJg
Dr. John Cush @RheumNow ( View Tweet )
1 day ago
Evidence-Based Dietary Recommendations for Gout Gout, historically referred to as the ā€œdisease of kings,ā€ was once associated with a lifestyle of excess. Today, it is more appropriate to refer to gout as a ā€œdisease of commoners,ā€ as it is the most common inflammatory arthritis https://t.co/uIrSeOjxJZ
Dr. John Cush @RheumNow ( View Tweet )
1 day ago
3 Rx are FDA approved for hidradenitis supprativa (secukinumab, adalimumab, bimekizumab). New JAK1i Povorcitinib in STOP-HS1 and STOP-HS2 ph 3 PCTs (608/619 pts). Povo showed HiSCR50 ~42% vs PBO 29% @wk12. AE: acne, pharyngitis https://t.co/n3FJUOjNuo https://t.co/9YAmPqW44z
Dr. John Cush @RheumNow ( View Tweet )
1 day 21 hours ago
×